理学療法ジャーナル56巻3号

2022年03月発行

特集 筋—理学療法士の視点から捉える

パーキンソン病および類縁疾患と筋力

著者： 清水裕斗¹ 菊地豊¹

所属機関： ¹脳血管研究所附属美原記念病院神経難病リハビリテーション課

ページ範囲：P.307 - P.319

Point

●パーキンソン病患者の筋力低下は中枢性要因，末梢性要因，加齢性要因から捉えられる

●パーキンソン病患者の適切な筋力評価には，症例の運動症候のサブタイプ，筋収縮様式，関節角度・角速度，服薬状況を踏まえた評価が求められる

●パーキンソン病の筋力低下に対してはレジスタンストレーニングの有効性が一部示されているのみで，背景要因別にみたアプローチの開発が期待される

参考文献

1）Bloem BR, et al：Parkinson's disease. Lancet 2021；397：2284-2303

2）Allen NE, et al：Bradykinesia, muscle weakness and reduced muscle power in parkinson's disease. Movement Disorders 2009；24：1344-1351

3）Paul SS, et al：Reduced muscle strength is the major determinant of reduced leg muscle power in Parkinson's disease. Parkinsonism and Related Disorders 2012；18：974-977

4）Parkinson J：An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci 2002；14：223-236

5）Koller W, et al：Muscle strength testing in Parkinson's disease. Eur Neurol 1986；25：130-133

6）Yazar T, et al：Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson's disease. Neurol Sci 2018；39：1415-1421

7）Postuma RB, et al：Advances in markers of prodromal Parkinson disease. Nat Rev Neurol 2016；12：622-634

8）Gustafsson H, et al：Low muscle strength in late adolescence and Parkinson disease later in life. Neurology 2015；84：1862-1869

9）Seidler RD, et al：Multijoint movement control in Parkinson's disease. Exp Brain Res 2001；140：335-344

10）Pfann KD, et al：Control of movement distance in Parkinson's disease. Movement Disorders 2001；16：1048-1065

11）Hallet M, et al：A physiological mechanism of bradykinesia. Brain 1980；103：301-314

12）Nogaki H, et al：Movement velocity dependent muscle strength in Parkinson's disease. Acta Neurol Scand 1999；99：152-157

13）Kakinuma S, et al：Muscle weakness in Parkinson's disease：isokinetic study of the lower limbs. Eur Neurol 1998；39：218-222

14）Corcos DM, et al：Strength in Parkinson's disease：relationship to rate of force generation and clinical status. Ann Neurol 1996；39：79-88

15）Brown P, et al：Does parkinsonian action tremor contribute to muscle weakness in Parkinson's disease? Brain 1997；120（Pt 3）：401-408

16）David FJ, et al：Progressive resistance exercise restores some properties of the triphasic EMG pattern and improves bradykinesia：the PRET-PD randomized clinical trial. J Neurophysiol 2016；116：2298-2311

17）Ni M, et al：Power training induced change in bradykinesia and muscle power in Parkinson's disease. Parkinsonism Relat Disord 2016；23：37-44

18）Winter DA（著），長岡明紀，他（訳）：バイオメカニクス—人体運動の力学と制御，原著第4版．ラウンドフラット，2011

19）Delong M, et al：Changing views of basal ganglia circuits and circuit disorders. Clin EEG Neurosci 2010；41：61-67

20）de Hemptinne CT, et al：Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease. Nat Neurosci 2015；18：779-786

21）Bologna M, et al：Neurophysiological correlates of bradykinesia in Parkinson's disease. Brain 2018；141：2432-2444

22）Ellaway PH, et al：The relation between bradykinesia and excitability of the motor cortex assessed using transcranial magnetic stimulation in normal and parkinsonian subjects. Electroencephalogr Clin Neurophysiol 1995；97：169-178

23）Wilson H, et al：Cortical thinning across Parkinson's disease stages and clinical correlates. J Neurol Sci 2019；398：31-38

24）Gooch CL, et al：Motor unit number estimation：a technology and literature review. Muscle Nerve 2014；50：884-893

25）Caviness JN, et al：Motor unit number estimates in idiopathic Parkinson's disease. Parkinsonism Relat Disord 2002；8：161-164

26）Paul DA, et al：Peripheral neuropathy in Parkinson's disease. Neurol Sci 2020；41：2691-2701

27）Kelly NA, et al：Effects of aging and Parkinson's disease on motor unit remodeling：influence of resistance exercise training. J Appl Physiol 2018；124：888-898

28）難病情報センター：パーキンソン病（指定難病6）．http//www.nanbyou.or.jp/entry/169（2022年2月1日閲覧）

29）Cao MD, et al：Sarcopenia is recognized as an independent condition by an International Classification of Disease, Tenth Revision, Clinical Modification（ICD-10-CM）code. J Am Med Dir Assoc 2016；17：675-677

30）Kitamura A, et al：Sarcopenia：prevalence, associated factors, and the risk of mortality and disability in Japanese older adults. J Cachexia Sarcopenia Muscle 2020；25：30-38

31）Cai Y, et al：Sarcopenia in patients with parkinson's disease：a systematic review and meta-analysis. Front Neurol 2021；12：598035. doi：10.3389/fneur.2021.598035

32）Peball M, et al：Prevalence and associated factors of sarcopenia and frailty in Parkinson's disease：a cross-sectional study. Gerontology 2019；65：216-228

33）Yazar T, et al：Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson's disease. Neurol Sci 2018；39：1415-1421

34）Drey M, et al：Motoneuron loss is associated with sarcopenia. J Am Med Dir Assoc 2014；15：435-439

35）Vanitallie TB, et al：Parkinson disease：primacy of age as a risk factor for mitochondrial dysfunction. Metabolism 2008；57：50-55

36）Scalzo P, et al：Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance. Neuroscience Lett 2010；468：56-58

37）Drey M, et al：Associations between early markers of parkinson's disease and sarcopenia. Front Aging Neurosci 2017；9：53. doi：10.3389/fnagi.2017.00053

38）Chung SJ, et al：Temporalis muscle thickness as an indicator of sarcopenia is associated with long-term motor outcomes in Parkinson's disease. J Gerontol A Biol Sci Med Sci 2021；76：2242-2248

39）Clark BC, et al：Sarcopenia≠Dynapenia. J Gerontol A Biol Sci Med Sci 2008；63：829-834

40）Barichella MD, et al：Sarcopenia and dynapenia in patients with Parkinsonism. J Am Med Dir Assoc 2016；17：640-646

41）Cereda E, et al：Low cardiometabolic risk in Parkinson's disease is independent of nutritional status, body composition and fat distribution. Clin Nutr 2012；31：699-704

42）Marras C, et al：Therapy of Parkinson's disease subtypes. Neurotherapeutics 2020；17：1366-1377

43）Stebbins GT, et al：How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale：comparison with the unified Parkinson's disease rating scale. Mov Disord 2013；28：668-670

44）Eisinger RS, et al：Parkinson's disease motor subtype changes during 20 years of follow-up. Parkinsonism Relat Disord 2020；76：104-107

45）Ng ASL, et al：Utility of plasma neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease. Mol Neurodegener 2020；15：33. doi：10.1186/s13024-020-00385-5

46）Krenovsky JP, et al：Interrelation between sarcopenia and the number of motor neurons in patients with Parkinsonian syndromes. Gerontology 2020；66：409-415

47）Takamatsu Y, et al：Skeletal muscle loss and body composition in progressive supranuclear palsy：a retrospective cross-sectional study. PLoS One 2021；16：e0253079. doi：10.1371/journal.pone.0253079

48）Neely KA, et al：Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy. PLoS One 2013；8：e58403. doi：10.1371/journal.pone.0058403

49）Pang MY, et al：Influence of contraction type, speed, and joint angle on ankle muscle weakness in Parkinson's disease：implications for rehabilitation. Arch Phys Med Rehabil 2012；93：2352-2359

50）Corcos DM, et al：Strength in Parkinson's disease：relationship to rate of force generation and clinical status. Ann Neurol 1996；39：79-88

51）Bologna M, et al：Bradykinesia in early and advanced Parkinson's disease. J Neurol Sci 2016；369：286-291

52）Chen LK, et al：Asian working group for sarcopenia：2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 2020；21：300-307

53）Paolucci T, et al：Evidence of rehabilitative impact of progressive resistance training（prt）programs in parkinson disease：an umbrella review. Parkinsons Dis 2020；2020：9748091. doi：10.1155/2020/9748091

54）Oliveira MP, et al：Effect of resistance exercise on body structure and function, activity, and participation in individuals with Parkinson disease：a systematic review. Arch Phys Med Rehabil 2021；102：1998-2011

55）Barichella M, et al：Major nutritional issues in the management of Parkinson's disease. Mov Disord 2009；24：1881-1892

56）若林秀隆：PT・OT・STのためのリハビリテーション栄養—栄養ケアがリハを変える．pp2-6，医歯薬出版，2010

57）Liao CD, et al：Effects of protein supplementation combined with resistance exercise on body composition and physical function in older adults：a systematic review and meta-analysis. Am J Clin Nutr 2017；106：1078-1091

58）Komar B, et al：Effects of leucine-rich protein supplements on anthropometric parameter and muscle strength in the elderly：a systematic review and meta-analysis. J Nutr Health Aging 2015；19：437-446

59）Tsui JK, et al：The effects of dietary protein on the efficiency of L-dopa：a double-blind study. Neurology 1989；39：549-542

60）Barichella M, et al：Special low-protein foods ameliorate postprandial off in patients with advanced Parkinson's disease. Mov Disord 2006；21：1682-1687